Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308. Nouruzi S, Johnson F, Kumar S, Sivak O, et al. Oncol Rep 2024;52:132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nouruzi S, Johnson F, Kumar S, Sivak O, et al. Targeting adenocarcinoma and enzalutamide?resistant prostate cancer using the novel anti?androgen inhibitor ADA?308. Oncol Rep 2024;52:132.
PMID: 39129317